000 01332 a2200349 4500
005 20250516101143.0
264 0 _c20130205
008 201302s 0 0 eng d
022 _a1759-5053
024 7 _a10.1038/nrgastro.2012.125
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCleynen, Isabelle
245 0 0 _aParadoxical inflammation induced by anti-TNF agents in patients with IBD.
_h[electronic resource]
260 _bNature reviews. Gastroenterology & hepatology
_cSep 2012
300 _a496-503 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdalimumab
650 0 4 _aAntibodies, Monoclonal
_xadverse effects
650 0 4 _aAntibodies, Monoclonal, Humanized
_xadverse effects
650 0 4 _aArthritis
_xchemically induced
650 0 4 _aDisease Management
650 0 4 _aDrug Eruptions
_xepidemiology
650 0 4 _aHumans
650 0 4 _aInflammatory Bowel Diseases
_xdrug therapy
650 0 4 _aInfliximab
650 0 4 _aPrevalence
650 0 4 _aSarcoidosis
_xchemically induced
650 0 4 _aTumor Necrosis Factor-alpha
_xantagonists & inhibitors
700 1 _aVermeire, Séverine
773 0 _tNature reviews. Gastroenterology & hepatology
_gvol. 9
_gno. 9
_gp. 496-503
856 4 0 _uhttps://doi.org/10.1038/nrgastro.2012.125
_zAvailable from publisher's website
999 _c21910896
_d21910896